201 related articles for article (PubMed ID: 27517838)
21. A comparative study of the neuropsychiatric and neurocognitive phenotype in two microdeletion syndromes: velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes.
Zarchi O; Diamond A; Weinberger R; Abbott D; Carmel M; Frisch A; Michaelovsky E; Gruber R; Green T; Weizman A; Gothelf D
Eur Psychiatry; 2014 May; 29(4):203-10. PubMed ID: 24054518
[TBL] [Abstract][Full Text] [Related]
22. Psychotic symptoms influence the development of anterior cingulate BOLD variability in 22q11.2 deletion syndrome.
Zöller D; Padula MC; Sandini C; Schneider M; Scariati E; Van De Ville D; Schaer M; Eliez S
Schizophr Res; 2018 Mar; 193():319-328. PubMed ID: 28803847
[TBL] [Abstract][Full Text] [Related]
23. Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome.
Thompson CA; Karelis J; Middleton FA; Gentile K; Coman IL; Radoeva PD; Mehta R; Fremont WP; Antshel KM; Faraone SV; Kates WR
Am J Med Genet B Neuropsychiatr Genet; 2017 Apr; 174(3):295-314. PubMed ID: 28139055
[TBL] [Abstract][Full Text] [Related]
24. Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome.
Green T; Gothelf D; Glaser B; Debbane M; Frisch A; Kotler M; Weizman A; Eliez S
J Am Acad Child Adolesc Psychiatry; 2009 Nov; 48(11):1060-1068. PubMed ID: 19797984
[TBL] [Abstract][Full Text] [Related]
25. The emergence of psychotic experiences in the early adolescence of 22q11.2 Deletion Syndrome.
Chawner SJRA; Niarchou M; Doherty JL; Moss H; Owen MJ; van den Bree MBM
J Psychiatr Res; 2019 Feb; 109():10-17. PubMed ID: 30458299
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL
Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981
[TBL] [Abstract][Full Text] [Related]
27. White matter abnormalities in 22q11.2 deletion syndrome: preliminary associations with the Nogo-66 receptor gene and symptoms of psychosis.
Perlstein MD; Chohan MR; Coman IL; Antshel KM; Fremont WP; Gnirke MH; Kikinis Z; Middleton FA; Radoeva PD; Shenton ME; Kates WR
Schizophr Res; 2014 Jan; 152(1):117-23. PubMed ID: 24321711
[TBL] [Abstract][Full Text] [Related]
28. Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome.
Niarchou M; Calkins ME; Moore TM; Tang SX; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
Schizophr Bull; 2018 Jun; 44(4):824-833. PubMed ID: 29040797
[TBL] [Abstract][Full Text] [Related]
29. Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study.
Weisman O; Guri Y; Gur RE; McDonald-McGinn DM; Calkins ME; Tang SX; Emanuel B; Zackai EH; Eliez S; Schneider M; Schaer M; Kates WR; Antshel KM; Fremont W; Shashi V; Hooper SR; Armando M; Vicari S; Pontillo M; Kushan L; Jalbrzikowski M; Bearden CE; Cubells JF; Ousley OY; Walker EF; Simon TJ; Stoddard J; Niendam TA; van den Bree MBM; Gothelf D;
Schizophr Bull; 2017 Sep; 43(5):1079-1089. PubMed ID: 28204757
[TBL] [Abstract][Full Text] [Related]
30. Update on the 22q11.2 deletion syndrome and its relevance to schizophrenia.
Van L; Boot E; Bassett AS
Curr Opin Psychiatry; 2017 May; 30(3):191-196. PubMed ID: 28230630
[TBL] [Abstract][Full Text] [Related]
31. Assessing auditory processing endophenotypes associated with Schizophrenia in individuals with 22q11.2 deletion syndrome.
Francisco AA; Foxe JJ; Horsthuis DJ; DeMaio D; Molholm S
Transl Psychiatry; 2020 Mar; 10(1):85. PubMed ID: 32139692
[TBL] [Abstract][Full Text] [Related]
32. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
[TBL] [Abstract][Full Text] [Related]
33. Developmental trajectories of brain structure in adolescents with 22q11.2 deletion syndrome: a longitudinal study.
Gothelf D; Penniman L; Gu E; Eliez S; Reiss AL
Schizophr Res; 2007 Nov; 96(1-3):72-81. PubMed ID: 17804201
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Low-Dose Aripiprazole for Treatment of Psychotic Symptoms in a Patient with 22q11.2 Deletion Syndrome.
Kontoangelos K; Lazaratou E; Economou M; Yiannopoulou KG; Papageorgiou CC
Psychopharmacol Bull; 2020 Mar; 50(1):35-39. PubMed ID: 32214520
[TBL] [Abstract][Full Text] [Related]
35. The effectiveness and tolerability of pharmacotherapy for psychosis in 22q11.2 Deletion Syndrome: A systematic review.
Tanham M; Chen R; Warren N; Heussler H; Scott JG
Aust N Z J Psychiatry; 2024 May; 58(5):393-403. PubMed ID: 38383990
[TBL] [Abstract][Full Text] [Related]
36. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.
Schneider M; Debbané M; Bassett AS; Chow EW; Fung WL; van den Bree M; Owen M; Murphy KC; Niarchou M; Kates WR; Antshel KM; Fremont W; McDonald-McGinn DM; Gur RE; Zackai EH; Vorstman J; Duijff SN; Klaassen PW; Swillen A; Gothelf D; Green T; Weizman A; Van Amelsvoort T; Evers L; Boot E; Shashi V; Hooper SR; Bearden CE; Jalbrzikowski M; Armando M; Vicari S; Murphy DG; Ousley O; Campbell LE; Simon TJ; Eliez S;
Am J Psychiatry; 2014 Jun; 171(6):627-39. PubMed ID: 24577245
[TBL] [Abstract][Full Text] [Related]
37. Stimulant treatment effectiveness, safety and risk for psychosis in individuals with 22q11.2 deletion syndrome.
Basel D; Mosheva M; Maeder J; Schneider M; Shani S; Weinberger R; Eliez S; Gothelf D
Eur Child Adolesc Psychiatry; 2022 Sep; 31(9):1367-1375. PubMed ID: 33871687
[TBL] [Abstract][Full Text] [Related]
38. Functional Dysconnectivity in Ventral Striatocortical Systems in 22q11.2 Deletion Syndrome.
Tepper Á; Cuiza A; Alliende LM; Mena C; Ramirez-Mahaluf JP; Iruretagoyena B; Ornstein C; Fritsch R; Nachar R; González-Valderrama A; Undurraga J; Cruz JP; Tejos C; Fornito A; Repetto G; Crossley N
Schizophr Bull; 2022 Mar; 48(2):485-494. PubMed ID: 34931688
[TBL] [Abstract][Full Text] [Related]
39. Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.
Carmel M; Zarchi O; Michaelovsky E; Frisch A; Patya M; Green T; Gothelf D; Weizman A
J Psychiatr Res; 2014 Sep; 56():28-35. PubMed ID: 24853458
[TBL] [Abstract][Full Text] [Related]
40. Neuroanatomic predictors to prodromal psychosis in velocardiofacial syndrome (22q11.2 deletion syndrome): a longitudinal study.
Kates WR; Antshel KM; Faraone SV; Fremont WP; Higgins AM; Shprintzen RJ; Botti JA; Kelchner L; McCarthy C
Biol Psychiatry; 2011 May; 69(10):945-52. PubMed ID: 21195387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
